GMT Science
GMT Science provides medical tests that use the gut microbiome to help diagnose or manage chronic diseases. It uses high-resolution stool metagenomics and AI-driven data science to power in vitro diagnostics. Core tech includes BiomScope, a CE-marked IVD software that measures microbial species, genes and functions, and IOScope, its first product that predicts response to immune checkpoint inhibitors. The company collaborates with hospitals across Europe and North America and maintains a database of over 20,000 curated clinical samples to discover microbiome biomarkers. The market focus is clinical laboratories seeking microbiome-based diagnostics powered by standardized analytics.
GMT Science
GMT Science provides medical tests that use the gut microbiome to help diagnose or manage chronic diseases. It uses high-resolution stool metagenomics and AI-driven data science to power in vitro diagnostics. Core tech includes BiomScope, a CE-marked IVD software that measures microbial species, genes and functions, and IOScope, its first product that predicts response to immune checkpoint inhibitors. The company collaborates with hospitals across Europe and North America and maintains a database of over 20,000 curated clinical samples to discover microbiome biomarkers. The market focus is clinical laboratories seeking microbiome-based diagnostics powered by standardized analytics.